Confirmed speakers

  • Richard Loughlin
    Director, Contract Manufacturing
    Sanofi-Aventis
  • Robert Guzman Esq., RAC
    Senior Director QA/QC, Cleveland BioLabs, Inc.
    Partner, Guzman Law Offices, PLLC
  • Stefan Proniuk
    Sr. Director Product Development
    ARNO THERAPEUTICS
  • Jim Damon
    Regional Director External Manufacturing and New Business Development
    JOHNSON AND JOHNSON
  • Carl Accettura
    Senior Director Production & Supply Chain Management
    SUNOVION PHARMACEUTICALS INC
  • Rebecca Tholmer
    Manager Quality Systems
    BAXTER BIOSCIENCE

Risk Mitigation and Production Improvement through Efficient Supply Chain Management

Contract Manufacturing Organizations (CMOs) serve the pharmaceutical industry and provide comprehensive service from drug development through manufacturing, however not all CMOs function at the same rate. Pharmaceutical companies typically require organizations that are focused in one specific area of production, and thus the growth in CMOs is directly related to the urgency within the pharmaceutical community to find more efficient and cost effective ways of delivering their products. As a hiring firm looking for a partner, there are many key considerations to contemplate to ensure a successful technology transfer and commercial production.

Join us this coming December 5-7, 2011 at IQPC’s 13th Annual Contract Manufacturing for Pharmaceuticals and Biotech Conference in Philadelphia, PA to engage with your industry peers and learn from top experts in contract manufacturing. This conference will be taking an in-depth look at the future of strategic CMO outsourcing, assessing risk management of quality systems, audit process to ensure GMP, and tools to expedite your supply chain process, amongst other things within the pharma and biologics outsourcing field.

Testimonials

Very experienced speakers.
– Manager, CMQA, Solvay Pharmaceuticals
Good selection of speakers, who cover a wide spectrum of experiences; in- depth information provided to audience.
- Director, API Development, Intermune
It addressed a number of key issues of relevance and had a good balance of topics. A valuable meeting.
- Paul Briner, Prosidion Ltd
An excellent process review of external manufacturing.
- Bruno Chetail, Merck Serono
Interesting participants and concrete business options.
- CEO, Labiana Pharmaceuticals
Media Partners
new_median

[ Register Now ]